4.6 Article

Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology

期刊

JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
卷 23, 期 8, 页码 682-698

出版社

ZHEJIANG UNIV PRESS
DOI: 10.1631/jzus.B2200038

关键词

Curcumin; Network pharmacology; p53; Adenosine 5 '-monophosphate (AMP)-activated protein kinase (AMPK); Apoptosis; Autophagy

资金

  1. General Project of Shaanxi Science and Technology Plan [2021JM-472]
  2. Key Laboratory Project of Education Department of Shaanxi Province [21JS014, 21JS007]
  3. Subject Innovation Team of Shaanxi University of Chinese Medicine [2019-YL14]
  4. Postgraduate Student's Innovation Project of Shaanxi University of Chinese Medicine, China [2021-09]

向作者/读者索取更多资源

Curcuinin can treat hepatocellular carcinoma (HCC) through the p53 apoptotic pathway and the AMPK/Unc-51-like kinase 1 (ULK1) autophagy pathway, in which the mutual transformation of autophagy and apoptosis may occur through DRAM and p62.
Objective: To determine the potential molecular mechanisms underlying the therapeutic effect of curcumin on hepatocellular carcinoma (HCC) by network pharmacology and experimental in vitro validation. Methods: The predictive targets of curcumin or HCC were collected from several databases. the identified overlapping targets were crossed with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) platform. Two of the candidate pathways were selected to conduct an experimental verification. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium (MTI) assay was used to determine the effect of curcumin on the viability of HepG2 and LO2 cells. The apoptosis and autophagy of HepG2 cells were respectively detected by flow cytometry and transmission electron microscopy. Besides, western blot and real-time polymerase chain reaction (PCR) were employed to verify the p53 apoptotic pathway and adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) autophagy pathway. HepG2 cells were pretreated with pifithrin-alpha (PFT-alpha) and GSK690693 for further investigation. Results: The 167 pathways analyzed by KEGG included apoptosis, autophagy, p53, and AMPK pathways. The GO enrichment analysis demonstrated that curcumin was involved in cellular response to drug, regulation of apoptotic pathway, and so on. The in vitro experiments also confirmed that curcumin can inhibit the growth of HepG2 cells by promoting the apoptosis of p53 pathway and autophagy through the AMPK pathway. Furthermore, the protein and messenger RNA (mRNA) of the two pathways were downregulated in the inhibitor-pretreated group compared with the experimental group. The damage-regulated autophagy modulator (DRAM) in the PFT-alpha-pretreated group was downregulated, and p62 in the GSK690693-pretreated group was upregulated. Conclusions: Curcuinin can treat HCC through the p53 apoptotic pathway and the AMPK/Unc-51-like kinase 1 (ULK1) autophagy pathway, in which the mutual transformation of autophagy and apoptosis may occur through DRAM and p62.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据